middle.news
Biotron Raises $645K to Accelerate Hepatitis B Drug Development
11:45am on Friday 19th of December, 2025 AEDT
•
Healthcare
Read Story
Biotron Raises $645K to Accelerate Hepatitis B Drug Development
11:45am on Friday 19th of December, 2025 AEDT
Key Points
Rights issue raised $645,861 with 215 million shares and options issued
Shortfall of $878,733 remains, backed by Peak Asset Management
Funds allocated to HBV drug toxicology studies and production scale-up
Patent costs, ongoing R&D, and commercialization activities also funded
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Biotron (ASX:BIT)
OPEN ARTICLE